Literature DB >> 28935643

Transplant for NEMO: this and much, much more.

Dennis D Hickstein1, Luigi Notarangelo2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28935643      PMCID： PMC5609338          DOI： 10.1182/blood-2017-07-795930

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

1.  Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide.

Authors:  Shannon R McCurdy; Yvette L Kasamon; Christopher G Kanakry; Javier Bolaños-Meade; Hua-Ling Tsai; Margaret M Showel; Jennifer A Kanakry; Heather J Symons; Ivana Gojo; B Douglas Smith; Maria P Bettinotti; William H Matsui; Amy E Dezern; Carol Ann Huff; Ivan Borrello; Keith W Pratz; Douglas E Gladstone; Lode J Swinnen; Robert A Brodsky; Mark J Levis; Richard F Ambinder; Ephraim J Fuchs; Gary L Rosner; Richard J Jones; Leo Luznik
Journal:  Haematologica       Date:  2016-10-20       Impact factor: 9.941

2.  X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling.

Authors:  R Döffinger; A Smahi; C Bessia; F Geissmann; J Feinberg; A Durandy; C Bodemer; S Kenwrick; S Dupuis-Girod; S Blanche; P Wood; S H Rabia; D J Headon; P A Overbeek; F Le Deist; S M Holland; K Belani; D S Kumararatne; A Fischer; R Shapiro; M E Conley; E Reimund; H Kalhoff; M Abinun; A Munnich; A Israël; G Courtois; J L Casanova
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

3.  Nonmyeloablative allogeneic hematopoietic stem cell transplantation for GATA2 deficiency.

Authors:  Jennifer Grossman; Jennifer Cuellar-Rodriguez; Juan Gea-Banacloche; Christa Zerbe; Katherine Calvo; Thomas Hughes; Fran Hakim; Kristen Cole; Mark Parta; Alexandra Freeman; Steven M Holland; Dennis D Hickstein
Journal:  Biol Blood Marrow Transplant       Date:  2014-08-09       Impact factor: 5.742

4.  Novel splicing mutation in the NEMO (IKK-gamma) gene with severe immunodeficiency and heterogeneity of X-chromosome inactivation.

Authors:  Karen Helene Ørstavik; Marianne Kristiansen; Gun Peggy Knudsen; Kari Storhaug; Ashild Vege; Kristin Eiklid; Tore G Abrahamsen; Asma Smahi; Jon Steen-Johnsen
Journal:  Am J Med Genet A       Date:  2006-01-01       Impact factor: 2.802

5.  Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.

Authors:  R H Buckley; S E Schiff; R I Schiff; L Markert; L W Williams; J L Roberts; L A Myers; F E Ward
Journal:  N Engl J Med       Date:  1999-02-18       Impact factor: 91.245

6.  Very low levels of donor CD18+ neutrophils following allogeneic hematopoietic stem cell transplantation reverse the disease phenotype in canine leukocyte adhesion deficiency.

Authors:  Thomas R Bauer; Kate E Creevy; Yu-chen Gu; Laura M Tuschong; Robert E Donahue; Mark E Metzger; Lisa J Embree; Tanya Burkholder; John D Bacher; Chris Romines; Marvin L Thomas; Lyn Colenda; Dennis D Hickstein
Journal:  Blood       Date:  2004-01-08       Impact factor: 22.113

7.  Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study.

Authors:  Tayfun Güngör; Pierre Teira; Mary Slatter; Georg Stussi; Polina Stepensky; Despina Moshous; Clementien Vermont; Imran Ahmad; Peter J Shaw; José Marcos Telles da Cunha; Paul G Schlegel; Rachel Hough; Anders Fasth; Karim Kentouche; Bernd Gruhn; Juliana F Fernandes; Silvy Lachance; Robbert Bredius; Igor B Resnick; Bernd H Belohradsky; Andrew Gennery; Alain Fischer; H Bobby Gaspar; Urs Schanz; Reinhard Seger; Katharina Rentsch; Paul Veys; Elie Haddad; Michael H Albert; Moustapha Hassan
Journal:  Lancet       Date:  2013-10-23       Impact factor: 79.321

8.  GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity.

Authors:  Michael A Spinner; Lauren A Sanchez; Amy P Hsu; Pamela A Shaw; Christa S Zerbe; Katherine R Calvo; Diane C Arthur; Wenjuan Gu; Christine M Gould; Carmen C Brewer; Edward W Cowen; Alexandra F Freeman; Kenneth N Olivier; Gulbu Uzel; Adrian M Zelazny; Janine R Daub; Christine D Spalding; Reginald J Claypool; Neelam K Giri; Blanche P Alter; Emily M Mace; Jordan S Orange; Jennifer Cuellar-Rodriguez; Dennis D Hickstein; Steven M Holland
Journal:  Blood       Date:  2013-11-13       Impact factor: 22.113

9.  Hematopoietic stem cell transplantation in 29 patients hemizygous for hypomorphic IKBKG/NEMO mutations.

Authors:  Charline Miot; Kohsuke Imai; Chihaya Imai; Anthony J Mancini; Zeynep Yesim Kucuk; Tokomki Kawai; Ryuta Nishikomori; Etsuro Ito; Isabelle Pellier; Sophie Dupuis Girod; Jeremie Rosain; Shinya Sasaki; Shanmuganathan Chandrakasan; Jana Pachlopnik Schmid; Tsubasa Okano; Estelle Colin; Alberto Olaya-Vargas; Marco Yamazaki-Nakashimada; Waseem Qasim; Sara Espinosa Padilla; Andrea Jones; Alfons Krol; Nyree Cole; Stephen Jolles; Jack Bleesing; Thomas Vraetz; Andrew R Gennery; Mario Abinun; Tayfun Güngör; Beatriz Costa-Carvalho; Antonio Condino-Neto; Paul Veys; Steven M Holland; Gulbu Uzel; Despina Moshous; Benedicte Neven; Stéphane Blanche; Stephan Ehl; Rainer Döffinger; Smita Y Patel; Anne Puel; Jacinta Bustamante; Erwin W Gelfand; Jean-Laurent Casanova; Jordan S Orange; Capucine Picard
Journal:  Blood       Date:  2017-07-05       Impact factor: 22.113
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.